PROVIDER PROFILE · NPI 1003486028
Jeffrey Hamrlicek
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
261
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
5
Brand share
52.1%
Top prescribed drugs
Ondansetron136 claims
Omeprazole67 claims
Meloxicam23 claims
Oxycodone Hcl23 claims
Cyclobenzaprine Hcl12 claims
QUALITY · MIPS · 2024
Final MIPS score
86.6
Quality
84.9
Cost
71.3
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.49%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE